{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T19:40:10Z","timestamp":1789414810853,"version":"build-2803163510"},"reference-count":138,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11095-025-03941-0","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T16:49:54Z","timestamp":1762447794000},"page":"2379-2404","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Bionanoconjugates in Neurodegeneration: Peptide\u2013Nanoparticle Alliances for Next-Generation Therapies"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9650-5921","authenticated-orcid":false,"given":"V. R.","family":"Ranjitha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashantha","family":"Kaalappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,6]]},"reference":[{"key":"3941_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40580-017-0103-4","volume":"4","author":"T Nagamune","year":"2007","unstructured":"Nagamune T. Biomolecular engineering for nanobio\/bionanotechnology. Nano Converg. 2007;4:9. https:\/\/doi.org\/10.1186\/s40580-017-0103-4.","journal-title":"Nano Converg"},{"key":"3941_CR2","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.37349\/eds.2023.00011","volume":"1","author":"MG Ciulla","year":"2023","unstructured":"Ciulla MG, Civera M, Sattin S, Kumar K. Nature-inspired and medicinally relevant short peptides. Explor Drug Sci. 2023;1:1440\u201371. https:\/\/doi.org\/10.37349\/eds.2023.00011.","journal-title":"Explor Drug Sci"},{"key":"3941_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2015.00211","volume":"3","author":"A Gro\u00df","year":"2016","unstructured":"Gro\u00df A, Hashimoto C, Sticht H, Eichler J. Synthetic peptides as protein mimics. Front Bioeng Biotechnol. 2016;3:211. https:\/\/doi.org\/10.3389\/fbioe.2015.00211.","journal-title":"Front Bioeng Biotechnol"},{"key":"3941_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26020430","volume":"26","author":"V Apostolopoulos","year":"2021","unstructured":"Apostolopoulos V, Bojarska J, Chai TT, Elnagdy S, Kaczmarek K, Matsoukas J, et al. A global review on short peptides: frontiers and perspectives. Molecules. 2021;26:430. https:\/\/doi.org\/10.3390\/molecules26020430.","journal-title":"Molecules"},{"key":"3941_CR5","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1021\/acs.molpharmaceut.7b00263","volume":"14","author":"F Li","year":"2017","unstructured":"Li F, Mahato RI. Bioconjugate therapeutics: current progress and future perspective. Mol Pharm. 2017;14:1321\u20134. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.7b00263.","journal-title":"Mol Pharm"},{"key":"3941_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.molliq.2024.124240","volume":"398","author":"V Figueroa","year":"2024","unstructured":"Figueroa V, Velasco B, Arellano LG, Dom\u00ednguez-Arca V, Camb\u00f3n A, Pardo A, et al. Role of surface functionalization and biomolecule structure on protein corona adsorption and conformation onto anisotropic metallic nanoparticles. J Mol Liq. 2024;398:124240. https:\/\/doi.org\/10.1016\/j.molliq.2024.124240.","journal-title":"J Mol Liq"},{"key":"3941_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2023.215530","volume":"500","author":"S Kim","year":"2024","unstructured":"Kim S, No YH, Sluyter R, Konstantinov K, Kim YH, Kim JH. Peptide-nanoparticle conjugates as a theranostic platform. Coord Chem Rev. 2024;500:215530. https:\/\/doi.org\/10.1016\/j.ccr.2023.215530.","journal-title":"Coord Chem Rev"},{"key":"3941_CR8","doi-asserted-by":"publisher","first-page":"100401","DOI":"10.1016\/j.hazadv.2024.100401","volume":"13","author":"UO Aigbe","year":"2024","unstructured":"Aigbe UO, Osibote AO. Green synthesis of metal oxide nanoparticles, and their various applications. J Hazard Mater. 2024;13:100401. https:\/\/doi.org\/10.1016\/j.hazadv.2024.100401.","journal-title":"J Hazard Mater"},{"key":"3941_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2021.03.033","author":"M Zhang","year":"2021","unstructured":"Zhang M, Gao S, Yang D, Fang Y, Lin X, Jin X, et al. Influencing factors and strategies of enhancing nanoparticles into tumors in vivo. Acta Pharm Sin B. 2021. https:\/\/doi.org\/10.1016\/j.apsb.2021.03.033.","journal-title":"Acta Pharm Sin B"},{"key":"3941_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2019.119491","volume":"224","author":"J Xie","year":"2019","unstructured":"Xie J, Shen Z, Anraku Y, Kataoka K, Chen X. Nanomaterial-based blood-brain-barrier (BBB) crossing strategies. Biomaterials. 2019;224:119491. https:\/\/doi.org\/10.1016\/j.biomaterials.2019.119491.","journal-title":"Biomaterials"},{"key":"3941_CR11","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/869269","volume":"2014","author":"RK Upadhyay","year":"2014","unstructured":"Upadhyay RK. Drug delivery systems, CNS protection, and the blood brain barrier. BioMed Res Int. 2014;2014:869269. https:\/\/doi.org\/10.1155\/2014\/869269.","journal-title":"BioMed Res Int"},{"key":"3941_CR12","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13052-018-0563-0","volume":"44","author":"CM Bellettato","year":"2018","unstructured":"Bellettato CM, Scarpa M. Possible strategies to cross the blood-brain barrier. Ital J Pediatr. 2018;44:131. https:\/\/doi.org\/10.1186\/s13052-018-0563-0.","journal-title":"Ital J Pediatr"},{"key":"3941_CR13","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/s0169-409x(02)00021-2","volume":"544","author":"FF Davis","year":"2002","unstructured":"Davis FF. The origin of pegnology. Adv Drug Deliv Rev. 2002;544:457\u20138. https:\/\/doi.org\/10.1016\/s0169-409x(02)00021-2.","journal-title":"Adv Drug Deliv Rev"},{"key":"3941_CR14","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jconrel.2008.08.012","volume":"132","author":"AS Hoffman","year":"2008","unstructured":"Hoffman AS. The origins and evolution of \u201ccontrolled\u201d drug delivery systems. J Control Release. 2008;132:153\u201363. https:\/\/doi.org\/10.1016\/j.jconrel.2008.08.012.","journal-title":"J Control Release"},{"key":"3941_CR15","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/polc.5070510111","volume":"51","author":"H Ringsdorf","year":"1975","unstructured":"Ringsdorf H. Structure and properties of pharmacologically active polymers. J Polym Sci. 1975;51:135\u201353. https:\/\/doi.org\/10.1002\/polc.5070510111.","journal-title":"J Polym Sci"},{"key":"3941_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/3-540-12796-8_10","author":"R Duncan","year":"2005","unstructured":"Duncan R, Kope\u010dek J. Soluble synthetic polymers as potential drug carriers. Polymers Med. 2005. https:\/\/doi.org\/10.1007\/3-540-12796-8_10.","journal-title":"Polymers Med"},{"key":"3941_CR17","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/0168-3659(90)90013-J","volume":"13","author":"C Damg\u00e9","year":"1990","unstructured":"Damg\u00e9 C, Michel C, Aprahamian M, Couvreur P, Devissaguet JP. Nanocapsules as carriers for oral peptide delivery. J Control Release. 1990;13:233\u20139. https:\/\/doi.org\/10.1016\/0168-3659(90)90013-J.","journal-title":"J Control Release"},{"key":"3941_CR18","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/s0945-053x(03)00083-0","volume":"22","author":"E Ruoslahti","year":"2003","unstructured":"Ruoslahti E. The RGD story: a personal account. Matrix Biol. 2003;22:150\u201365. https:\/\/doi.org\/10.1016\/s0945-053x(03)00083-0.","journal-title":"Matrix Biol"},{"key":"3941_CR19","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/0169-409X(95)00032-3","volume":"16","author":"VS Trubetskoy","year":"1995","unstructured":"Trubetskoy VS, Torchilin VP. Use of polyoxyethylene-lipid conjugates as long-circulating carriers for delivery of therapeutic and diagnostic agents. Adv Drug Deliv Rev. 1995;16:311\u201320. https:\/\/doi.org\/10.1016\/0169-409X(95)00032-3.","journal-title":"Adv Drug Deliv Rev"},{"key":"3941_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1039\/9781849735292-00003","volume-title":"Nanostructured biomaterials for overcoming biological barriers","author":"MJ Alonso","year":"2012","unstructured":"Alonso MJ, Couvreur P. Historical view of the design and development of nanocarriers for overcoming biological barriers. In: Maria JA, Noemi SC, editors. Nanostructured biomaterials for overcoming biological barriers. Cambridge UK: The royal society of chemistry; 2012. p. 3\u201336."},{"key":"3941_CR21","doi-asserted-by":"publisher","first-page":"3228","DOI":"10.3390\/molecules26113228","volume":"26","author":"X Li","year":"2021","unstructured":"Li X, Jian M, Sun Y, Zhu Q, Wang Z. The peptide functionalized inorganic nanoparticles for cancer-related bioanalytical and biomedical applications. Molecules. 2021;26:3228. https:\/\/doi.org\/10.3390\/molecules26113228.","journal-title":"Molecules"},{"key":"3941_CR22","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1098\/rsta.2009.0273","volume":"368","author":"RA Sperling","year":"2010","unstructured":"Sperling RA, Parak WJ. Surface modification, functionalization and bioconjugation of colloidal inorganic nanoparticles. Philos Trans R Soc Lond A Math Phys Eng Sci. 2010;368:1333\u201383. https:\/\/doi.org\/10.1098\/rsta.2009.0273.","journal-title":"Philos Trans R Soc Lond A Math Phys Eng Sci"},{"key":"3941_CR23","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1021\/bc8003028","volume":"20","author":"Z Krpetic","year":"2009","unstructured":"Krpetic Z, Nativo P, Porta F, Brust M. A multidentate peptide for stabilization and facile bioconjugation of gold nanoparticles. Bioconjug Chem. 2009;20:619\u201324. https:\/\/doi.org\/10.1021\/bc8003028.","journal-title":"Bioconjug Chem"},{"key":"3941_CR24","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1039\/c9sc06497d","volume":"11","author":"J Zhang","year":"2020","unstructured":"Zhang J, Mou L, Jiang X. Surface chemistry of gold nanoparticles for health-related applications. Chem Sci. 2020;11:923\u201336. https:\/\/doi.org\/10.1039\/c9sc06497d.","journal-title":"Chem Sci"},{"key":"3941_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12645-016-0013-x","volume":"7","author":"S Kalmodia","year":"2016","unstructured":"Kalmodia S, Vandhana S, Tejaswini Rama BR, Jayashree B, Sreenivasan Seethalakshmi T, Umashankar V, et al. Bio-conjugation of antioxidant peptide on surface-modified gold nanoparticles: a novel approach to enhance the radical scavenging property in cancer cell. Cancer Nanotechnol. 2016;7:1. https:\/\/doi.org\/10.1186\/s12645-016-0013-x.","journal-title":"Cancer Nanotechnol"},{"key":"3941_CR26","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1021\/acsomega.1c05546","volume":"7","author":"M Abbas","year":"2022","unstructured":"Abbas M, Susapto HH, Hauser CA. Synthesis and organization of gold-peptide nanoparticles for catalytic activities. ACS Omega. 2022;7:2082\u201390. https:\/\/doi.org\/10.1021\/acsomega.1c05546.","journal-title":"ACS Omega"},{"key":"3941_CR27","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1021\/bc2001215","volume":"22","author":"NTT Tran","year":"2011","unstructured":"Tran NTT, Wang TH, Lin CY, Tsai YC, Lai CH, Tai Y, et al. Direct synthesis of rev peptide-conjugated gold nanoparticles and their application in cancer therapeutics. Bioconjug Chem. 2011;22:1394\u2013401. https:\/\/doi.org\/10.1021\/bc2001215.","journal-title":"Bioconjug Chem"},{"key":"3941_CR28","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1002\/chem.200601492","volume":"13","author":"S Si","year":"2007","unstructured":"Si S, Mandal TK. Tryptophan-based peptides to synthesize gold and silver nanoparticles: a mechanistic and kinetic study. Chem Eur J. 2007;13:3160\u20138. https:\/\/doi.org\/10.1002\/chem.200601492.","journal-title":"Chem Eur J"},{"key":"3941_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s13036-019-0191-2","volume":"13","author":"MP Wickramathilaka","year":"2019","unstructured":"Wickramathilaka MP, Tao BY. Characterization of covalent crosslinking strategies for synthesizing DNA-based bioconjugates. J Biol Eng. 2019;13:63. https:\/\/doi.org\/10.1186\/s13036-019-0191-2.","journal-title":"J Biol Eng"},{"key":"3941_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-66230-3","author":"S Joshi","year":"2020","unstructured":"Joshi S, Siddiqui R, Sharma P, Kumar R, Verma G, Saini A. Green synthesis of peptide functionalized reduced graphene oxide (rGO) nano bioconjugate with enhanced antibacterial activity. Sci Rep. 2020. https:\/\/doi.org\/10.1038\/s41598-020-66230-3.","journal-title":"Sci Rep"},{"key":"3941_CR31","doi-asserted-by":"publisher","first-page":"7013","DOI":"10.1039\/C4CS00139G","volume":"43","author":"W Tang","year":"2014","unstructured":"Tang W, Becker ML. \u201cClick\u201d reactions: a versatile toolbox for the synthesis of peptide-conjugates. Chem Soc Rev. 2014;43:7013\u201339. https:\/\/doi.org\/10.1039\/C4CS00139G.","journal-title":"Chem Soc Rev"},{"key":"3941_CR32","doi-asserted-by":"publisher","DOI":"10.1039\/C4RA07574A","author":"X Wang","year":"2014","unstructured":"Wang X, Gobbo P, Suchy M, Workentin MS, Hudson RH. Peptide-decorated gold nanoparticles via strain-promoted azide\u2013alkyne cycloaddition and post assembly deprotection. RSC Adv. 2014. https:\/\/doi.org\/10.1039\/C4RA07574A.","journal-title":"RSC Adv"},{"key":"3941_CR33","doi-asserted-by":"publisher","first-page":"6182","DOI":"10.1039\/C7SC01447C","volume":"8","author":"Y Liu","year":"2017","unstructured":"Liu Y, Hou W, Sun H, Cui C, Zhang L, Jiang Y, et al. Thiol\u2013ene click chemistry: a biocompatible way for orthogonal bioconjugation of colloidal nanoparticles. Chem Sci. 2017;8:6182\u20137. https:\/\/doi.org\/10.1039\/C7SC01447C.","journal-title":"Chem Sci"},{"key":"3941_CR34","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jconrel.2018.03.002","volume":"282","author":"L Mart\u00ednez-Jothar","year":"2018","unstructured":"Mart\u00ednez-Jothar L, Doulkeridou S, Schiffelers RM, Torano JS, Oliveira S, van Nostrum CF, et al. Insights into maleimide-thiol conjugation chemistry: conditions for efficient surface functionalization of nanoparticles for receptor targeting. J Control Release. 2018;282:101\u20139. https:\/\/doi.org\/10.1016\/j.jconrel.2018.03.002.","journal-title":"J Control Release"},{"key":"3941_CR35","doi-asserted-by":"publisher","first-page":"213862","DOI":"10.1016\/j.bioadv.2024.213862","volume":"161","author":"PP Arayici","year":"2024","unstructured":"Arayici PP, Coksu I, Ozbek T, Acar S. Targeted delivery of rifaximin using P6. 2-decorated bifunctional PLGA nanoparticles for combating Staphylococcus aureus infections. Biomaterials Advances. 2024;161:213862. https:\/\/doi.org\/10.1016\/j.bioadv.2024.213862.","journal-title":"Biomaterials Advances"},{"key":"3941_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.123936","volume":"654","author":"A Pant","year":"2024","unstructured":"Pant A, Singh G, Barnwal RP, Sharma T, Singh B. QbD-driven development and characterization of superparamagnetic iron oxide nanoparticles (SPIONS) of a bone-targeting peptide for early detection of osteoporosis. Int J Pharm. 2024;654:123936. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.123936.","journal-title":"Int J Pharm"},{"key":"3941_CR37","doi-asserted-by":"publisher","first-page":"16771","DOI":"10.1021\/jacs.3c04768","volume":"145","author":"V R\u00fcck","year":"2023","unstructured":"R\u00fcck V, Mishra NK, S\u00f8rensen KK, Liisberg MB, Sloth AB, Cerretani C, et al. Bioconjugation of a near-infrared DNA-stabilized silver nanocluster to peptides and human insulin by copper-free click chemistry. J Am Chem Soc. 2023;145:16771\u20137. https:\/\/doi.org\/10.1021\/jacs.3c04768.","journal-title":"J Am Chem Soc"},{"key":"3941_CR38","doi-asserted-by":"publisher","first-page":"5581","DOI":"10.2147\/IJN.S376358","volume":"17","author":"AK Mohan","year":"2022","unstructured":"Mohan AK, Kumar MMTRS, Kumar GSV. Multi-layered PLGA-PEI nanoparticles functionalized with TKD peptide for targeted delivery of Pep5 to breast tumor cells and spheroids. Int J Nanomed. 2022;17:5581\u2013600. https:\/\/doi.org\/10.2147\/IJN.S376358.","journal-title":"Int J Nanomed"},{"key":"3941_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.saa.2023.123552","volume":"306","author":"B Kalyani Bhardwaj","year":"2024","unstructured":"Kalyani Bhardwaj B, Suresh PS. Synthesis, characterization and multi-spectroscopic DNA\/HSA interaction studies of synthetic human follicle-stimulating hormone beta 33\u201353 peptide conjugated PEGylated graphene oxide nanoparticles. Spectrochim Acta A Mol Biomol Spectrosc. 2024;306:123552. https:\/\/doi.org\/10.1016\/j.saa.2023.123552.","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"key":"3941_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.106218","volume":"101","author":"A Sattari-Maraji","year":"2024","unstructured":"Sattari-Maraji A, Nikchi M, Shahmiri M, Ahadi EM, Firoozpour L, Moazeni E, et al. Jellein-I-conjugated gold nanoparticles: insights into the antibacterial, antibiofilm activities against MRSA, and anticancer properties. J Drug Deliv Sci Technol. 2024;101:106218. https:\/\/doi.org\/10.1016\/j.jddst.2024.106218.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3941_CR41","doi-asserted-by":"publisher","unstructured":"Fu X, Yang Y, Li X, Lai H, Huang Y, He L, ... Chen T (2016) RGD peptide-conjugated selenium nanoparticles: antiangiogenesis by suppressing VEGF-VEGFR2-ERK\/AKT pathway. Nanomed Nanotechnol Biol Med 6:1627\u201339. https:\/\/doi.org\/10.1016\/j.nano.2016.01.012","DOI":"10.1016\/j.nano.2016.01.012"},{"key":"3941_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.106337","volume":"102","author":"N Rostami","year":"2024","unstructured":"Rostami N, Ghebleh A, Noei H, Rizi ZS, Moeinzadeh A, Nikzad A, et al. Peptide-functionalized polymeric nanoparticles for delivery of curcumin to cancer cells. J Drug Deliv Sci Technol. 2024;102:106337. https:\/\/doi.org\/10.1016\/j.jddst.2024.106337.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3941_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.arabjc.2024.105735","volume":"17","author":"H Sun","year":"2024","unstructured":"Sun H, Dong S, Kong L, Wang R, Zhao J, Guan Y, et al. Cationic anticancer peptide L-K6-modified and doxorubicin-loaded mesoporous silica nanoparticles reverse multidrug resistance of breast cancer. Arab J Chem. 2024;17:105735. https:\/\/doi.org\/10.1016\/j.arabjc.2024.105735.","journal-title":"Arab J Chem"},{"key":"3941_CR44","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.bioactmat.2023.05.016","volume":"28","author":"S Song","year":"2023","unstructured":"Song S, Shim MK, Yang S, Lee J, Yun WS, Cho H, et al. All-in-one glycol chitosan nanoparticles for co-delivery of doxorubicin and anti-PD-L1 peptide in cancer immunotherapy. Bioact Mater. 2023;28:358\u201375. https:\/\/doi.org\/10.1016\/j.bioactmat.2023.05.016.","journal-title":"Bioact Mater"},{"key":"3941_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s11671-023-03870-0","volume":"18","author":"H Huang","year":"2023","unstructured":"Huang H, Chen H, Shou D, Quan Y, Cheng J, Chen H, et al. Engineering siRNA-loaded and RGDfC-targeted selenium nanoparticles for highly efficient silencing of DCBLD2 gene for colorectal cancer treatment. Discover Nano. 2023;18:94. https:\/\/doi.org\/10.1186\/s11671-023-03870-0.","journal-title":"Discover Nano"},{"key":"3941_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.122618","volume":"633","author":"C Conte","year":"2023","unstructured":"Conte C, Longobardi G, Barbieri A, Palma G, Luciano A, Dal Poggetto G, et al. Non-covalent strategies to functionalize polymeric nanoparticles with NGR peptides for targeting breast cancer. Int J Pharm. 2023;633:122618. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.122618.","journal-title":"Int J Pharm"},{"key":"3941_CR47","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1080\/03639045.2019.1634090","volume":"45","author":"VR Ranjitha","year":"2019","unstructured":"Ranjitha VR, Muddegowda U, Ravishankar Rai V. Potent activity of bioconjugated peptide and selenium nanoparticles against colorectal adenocarcinoma cells. Drug Dev Ind Pharm. 2019;45:1496\u2013505. https:\/\/doi.org\/10.1080\/03639045.2019.1634090.","journal-title":"Drug Dev Ind Pharm"},{"key":"3941_CR48","doi-asserted-by":"publisher","DOI":"10.1007\/s11051-020-04799-6","volume":"22","author":"M Gakiya-Teruya","year":"2020","unstructured":"Gakiya-Teruya M, Palomino-Marcelo L, Pierce S, Angeles-Boza AM, Krishna V, Rodriguez-Reyes JCF. Enhanced antimicrobial activity of silver nanoparticles conjugated with synthetic peptide by click chemistry. J Nanopart Res. 2020;22:90. https:\/\/doi.org\/10.1007\/s11051-020-04799-6.","journal-title":"J Nanopart Res"},{"key":"3941_CR49","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1039\/d1ra05980g","volume":"12","author":"P Maraming","year":"2020","unstructured":"Maraming P, Daduang J, Kah JCY. Conjugation with gold nanoparticles improves the stability of the KT2 peptide and maintains its anticancer properties. RSC Adv. 2020;12:319\u201325. https:\/\/doi.org\/10.1039\/d1ra05980g.","journal-title":"RSC Adv"},{"key":"3941_CR50","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s40199-019-00324-w","volume":"28","author":"M Esfandyari-Manesh","year":"2020","unstructured":"Esfandyari-Manesh M, Abdi M, Talasaz AH, Ebrahimi SM, Atyabi F, Dinarvand R. S2p peptide-conjugated PLGA-Maleimide-PEG nanoparticles containing Imatinib for targeting drug delivery to atherosclerotic plaques. DARU J Pharm Sci. 2020;28:131\u20138. https:\/\/doi.org\/10.1007\/s40199-019-00324-w.","journal-title":"DARU J Pharm Sci"},{"key":"3941_CR51","doi-asserted-by":"publisher","first-page":"128491","DOI":"10.1016\/j.colsurfa.2022.128491","volume":"640","author":"X Xu","year":"2022","unstructured":"Xu X, Liu Y, Yang Y, Wu J, Cao M, Sun L. One-pot synthesis of functional peptide-modified gold nanoparticles for gene delivery. Colloids Surf A: Physicochem Eng Asp. 2022;640:128491. https:\/\/doi.org\/10.1016\/j.colsurfa.2022.128491.","journal-title":"Colloids Surf A: Physicochem Eng Asp"},{"key":"3941_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-016-0211-z","volume":"14","author":"AA Chaudhari","year":"2016","unstructured":"Chaudhari AA, Ashmore DA, Nath SD, Kate K, Dennis V, Singh SR, et al. A novel covalent approach to bio-conjugate silver coated single walled carbon nanotubes with antimicrobial peptide. J Nanobiotechnol. 2016;14:58. https:\/\/doi.org\/10.1186\/s12951-016-0211-z.","journal-title":"J Nanobiotechnol"},{"key":"3941_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116959","volume":"177","author":"T Xing","year":"2024","unstructured":"Xing T, Wang X, Xu Y, Sun F, Chen M, Yan Q, et al. Click method preserves but EDC method compromises the therapeutic activities of the peptide-activated hydrogels for critical ischemic vessel regeneration. Biomed Pharmacother. 2024;177:116959. https:\/\/doi.org\/10.1016\/j.biopha.2024.116959.","journal-title":"Biomed Pharmacother"},{"key":"3941_CR54","doi-asserted-by":"publisher","first-page":"14639","DOI":"10.1021\/la403245h","volume":"29","author":"J Bolley","year":"2013","unstructured":"Bolley J, Guenin E, Lievre N, Lecouvey M, Soussan M, Lalatonne Y, et al. Carbodiimide versus click chemistry for nanoparticle surface functionalization: a comparative study for the elaboration of multimodal superparamagnetic nanoparticles targeting \u03b1v\u03b23 integrins. Langmuir. 2013;29:14639\u201347. https:\/\/doi.org\/10.1021\/la403245h.","journal-title":"Langmuir"},{"key":"3941_CR55","doi-asserted-by":"crossref","unstructured":"Algar WR (2017) A brief introduction to traditional bioconjugate chemistry. Chemoselective and bioorthogonal ligation reactions: concepts and applications, pp 1\u201336","DOI":"10.1002\/9783527683451.ch1"},{"key":"3941_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/ph15101283","volume":"15","author":"O Al Musaimi","year":"2022","unstructured":"Al Musaimi O, Lombardi L, Williams DR, Albericio F. Strategies for improving peptide stability and delivery. Pharmaceuticals. 2022;15:1283. https:\/\/doi.org\/10.3390\/ph15101283.","journal-title":"Pharmaceuticals"},{"key":"3941_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2021.736519","volume":"9","author":"S Locarno","year":"2021","unstructured":"Locarno S, Bucci R, Impresari E, Gelmi ML, Pellegrino S, Clerici F. Ultrashort peptides and gold nanoparticles: influence of constrained amino acids on colloidal stability. Front Chem. 2021;9:736519. https:\/\/doi.org\/10.3389\/fchem.2021.736519.","journal-title":"Front Chem"},{"key":"3941_CR58","doi-asserted-by":"publisher","first-page":"25371","DOI":"10.1021\/jacs.4c10533","volume":"146","author":"A Sahni","year":"2024","unstructured":"Sahni A, Ritchey JL, Qian Z, Pei D. Cell-penetrating peptides translocate across the plasma membrane by inducing vesicle budding and collapse. J Am Chem Soc. 2024;146:25371\u201382. https:\/\/doi.org\/10.1021\/jacs.4c10533.","journal-title":"J Am Chem Soc"},{"key":"3941_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.mito.2024.101906","volume":"78","author":"M Dowaidar","year":"2024","unstructured":"Dowaidar M. Cell-penetrating peptides with nanoparticles hybrid delivery vectors and their uptake pathways. Mitochondrion. 2024;78:101906. https:\/\/doi.org\/10.1016\/j.mito.2024.101906.","journal-title":"Mitochondrion"},{"key":"3941_CR60","doi-asserted-by":"publisher","first-page":"37734","DOI":"10.1021\/acsami.4c07821","volume":"16","author":"M Walter","year":"2024","unstructured":"Walter M, Bresinsky M, Zimmer O, Pockes S, Goepferich A. Conditional cell-penetrating peptide exposure as selective nanoparticle uptake signal. ACS Appl Mater Interfaces. 2024;16:37734\u201347. https:\/\/doi.org\/10.1021\/acsami.4c07821.","journal-title":"ACS Appl Mater Interfaces"},{"key":"3941_CR61","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.1016\/j.biomaterials.2008.08.004","volume":"29","author":"KS Rao","year":"2008","unstructured":"Rao KS, Reddy MK, Horning JL, Labhasetwar V. TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugs. Biomaterials. 2008;29:4429\u201338. https:\/\/doi.org\/10.1016\/j.biomaterials.2008.08.004.","journal-title":"Biomaterials"},{"key":"3941_CR62","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1021\/acs.molpharmaceut.2c00755","volume":"20","author":"N Shadmani","year":"2023","unstructured":"Shadmani N, Makvandi P, Parsa M, Azadi A, Nedaei K, Mozafari N, et al. Enhancing methotrexate delivery in the brain by mesoporous silica nanoparticles functionalized with cell-penetrating peptide using in vivo and ex vivo monitoring. Mol Pharm. 2023;20:1531\u201348. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.2c00755.","journal-title":"Mol Pharm"},{"key":"3941_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2022.102633","volume":"48","author":"A Mwema","year":"2023","unstructured":"Mwema A, Bottemanne P, Paquot A, Ucakar B, Vanvarenberg K, Alhouayek M, et al. Lipid nanocapsules for the nose-to-brain delivery of the anti-inflammatory bioactive lipid PGD2-G. Nanomedicine. 2023;48:102633. https:\/\/doi.org\/10.1016\/j.nano.2022.102633.","journal-title":"Nanomedicine"},{"key":"3941_CR64","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12951-020-00766-4","volume":"19","author":"Y Lin","year":"2021","unstructured":"Lin Y, Wan Y, Du X, Li J, Wei J, Li T, et al. TAT-modified serum albumin nanoparticles for sustained-release of tetramethylpyrazine and improved targeting to spinal cord injury. J Nanobiotechnol. 2021;19:28. https:\/\/doi.org\/10.1186\/s12951-020-00766-4.","journal-title":"J Nanobiotechnol"},{"key":"3941_CR65","doi-asserted-by":"publisher","first-page":"8440","DOI":"10.1016\/j.ijpharm.2012.07.029","volume":"436","author":"H Xia","year":"2012","unstructured":"Xia H, Gao X, Gu G, Liu Z, Hu Q, Tu Y, et al. Penetratin-functionalized PEG-PLA nanoparticles for brain drug delivery. Int J Pharm. 2012;436:8440\u2013850. https:\/\/doi.org\/10.1016\/j.ijpharm.2012.07.029.","journal-title":"Int J Pharm"},{"key":"3941_CR66","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1021\/acs.molpharmaceut.4c00870","volume":"22","author":"CE Muolokwu","year":"2025","unstructured":"Muolokwu CE, Gothwal A, Kanekiyo T, Singh J. Synthesis and characterization of transferrin and cell-penetrating peptide-functionalized liposomal nanoparticles to deliver plasmid ApoE2 in vitro and in vivo in mice. Mol Pharm. 2025;22:229\u201341. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.4c00870.","journal-title":"Mol Pharm"},{"key":"3941_CR67","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.1021\/acs.molpharmaceut.3c00031","volume":"20","author":"A Gothwal","year":"2023","unstructured":"Gothwal A, Lamptey RNL, Singh J. Multifunctionalized cationic chitosan polymeric micelles polyplexed with pVGF for noninvasive delivery to the mouse brain through the intranasal route for developing therapeutics for Alzheimer\u2019s disease. Mol Pharm. 2023;20:3009\u201319. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.3c00031.","journal-title":"Mol Pharm"},{"key":"3941_CR68","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jconrel.2016.08.006","volume":"238","author":"D Carradori","year":"2016","unstructured":"Carradori D, Saulnier P, Pr\u00e9at V, des Rieux A, Eyer J. NFL-lipid nanocapsules for brain neural stem cell targeting in vitro and in vivo. J Control Release. 2016;238:253\u201362. https:\/\/doi.org\/10.1016\/j.jconrel.2016.08.006.","journal-title":"J Control Release"},{"key":"3941_CR69","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ejpb.2020.05.001","volume":"152","author":"T Kanazawa","year":"2020","unstructured":"Kanazawa T, Taki H, Okada H. Nose-to-brain drug delivery system with ligand\/cell-penetrating peptide-modified polymeric nano-micelles for intracerebral gliomas. Eur J Pharm Biopharm. 2020;152:85\u201394. https:\/\/doi.org\/10.1016\/j.ejpb.2020.05.001.","journal-title":"Eur J Pharm Biopharm"},{"key":"3941_CR70","doi-asserted-by":"publisher","first-page":"897","DOI":"10.2217\/nnm.10.74","volume":"5","author":"S Guerrero","year":"2010","unstructured":"Guerrero S, Araya E, Fiedler JL, Arias JI, Adura C, Albericio F, et al. Improving the brain delivery of gold nanoparticles by conjugation with an amphipathic peptide. Nanomedicine. 2010;5:897\u2013913. https:\/\/doi.org\/10.2217\/nnm.10.74.","journal-title":"Nanomedicine"},{"issue":"23","key":"3941_CR71","doi-asserted-by":"publisher","DOI":"10.3390\/nano13233004","volume":"13","author":"Y Wu","year":"2023","unstructured":"Wu Y, Angelova A. Recent uses of lipid nanoparticles, cell-penetrating and bioactive peptides for the development of brain-targeted nanomedicines against neurodegenerative disorders. Nanomaterials. 2023;13(23):3004. https:\/\/doi.org\/10.3390\/nano13233004.","journal-title":"Nanomaterials"},{"key":"3941_CR72","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.3390\/cells12121637","volume":"12","author":"Y Nie","year":"2023","unstructured":"Nie Y, Fu G, Leng Y. Nuclear delivery of nanoparticle-based drug delivery systems by nuclear localization signals. Cells. 2023;12:1637. https:\/\/doi.org\/10.3390\/cells12121637.","journal-title":"Cells"},{"key":"3941_CR73","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12964-021-00741-y","volume":"19","author":"J Lu","year":"2021","unstructured":"Lu J, Wu T, Zhang B, Liu S, Song W, Qiao J, et al. Types of nuclear localization signals and mechanisms of protein import into the nucleus. Cell Commun Signal. 2021;19:60. https:\/\/doi.org\/10.1186\/s12964-021-00741-y.","journal-title":"Cell Commun Signal"},{"key":"3941_CR74","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1038\/s41598-017-01853-7","volume":"7","author":"KM Smith","year":"2017","unstructured":"Smith KM, Himiari Z, Tsimbalyuk S, Forwood JK. Structural basis for Importin-\u03b1 binding of the human immunodeficiency virus Tat. Sci Rep. 2017;7:1650. https:\/\/doi.org\/10.1038\/s41598-017-01853-7.","journal-title":"Sci Rep"},{"key":"3941_CR75","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1007\/s10439-009-9768-0","volume":"37","author":"N Nitin","year":"2009","unstructured":"Nitin N, LaConte L, Rhee WJ, Bao G. Tat peptide is capable of importing large nanoparticles across nuclear membrane in digitonin permeabilized cells. Ann Biomed Eng. 2009;37:2018\u2013277. https:\/\/doi.org\/10.1007\/s10439-009-9768-0.","journal-title":"Ann Biomed Eng"},{"key":"3941_CR76","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1021\/acsami.5b10295","volume":"8","author":"AR Maity","year":"2016","unstructured":"Maity AR, Stepensky D. Efficient subcellular targeting to the cell nucleus of quantum dots densely decorated with a nuclear localization sequence peptide. ACS Appl Mater Interfaces. 2016;8:2001\u20139. https:\/\/doi.org\/10.1021\/acsami.5b10295.","journal-title":"ACS Appl Mater Interfaces"},{"key":"3941_CR77","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1080\/09205063.2020.1815496","volume":"32","author":"J Lee","year":"2021","unstructured":"Lee J, Kwon YE, Kim Y, Choi JS. Enhanced transfection efficiency of low generation PAMAM dendrimer conjugated with the nuclear localization signal peptide derived from herpesviridae. J Biomater Sci Polym Ed. 2021;32:22\u201341. https:\/\/doi.org\/10.1080\/09205063.2020.1815496.","journal-title":"J Biomater Sci Polym Ed"},{"key":"3941_CR78","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1021\/acs.nanolett.4c05186","volume":"25","author":"EL Han","year":"2025","unstructured":"Han EL, Tang S, Kim D, Murray AM, Swingle KL, Hamilton AG, et al. Peptide-functionalized lipid nanoparticles for targeted systemic mRNA delivery to the brain. Nano Lett. 2025;25:800\u201310. https:\/\/doi.org\/10.1021\/acs.nanolett.4c05186.","journal-title":"Nano Lett"},{"key":"3941_CR79","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.bioactmat.2020.08.017","volume":"6","author":"Y Han","year":"2021","unstructured":"Han Y, Gao C, Wang H, Sun J, Liang M, Feng Y, et al. Macrophage membrane-coated nanocarriers co-modified by RVG29 and TPP improve brain neuronal mitochondria-targeting and therapeutic efficacy in Alzheimer\u2019s disease mice. Bioact Mater. 2021;6:529\u201342. https:\/\/doi.org\/10.1016\/j.bioactmat.2020.08.017.","journal-title":"Bioact Mater"},{"key":"3941_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11095-020-02865-1","volume":"37","author":"RGR Pinheiro","year":"2020","unstructured":"Pinheiro RGR, Granja A, Loureiro JA, Pereira MC, Pinheiro M, Neves AR, et al. RVG29-functionalized lipid nanoparticles for quercetin brain delivery and alzheimer\u2019s disease. Pharm Res. 2020;37:1\u201312. https:\/\/doi.org\/10.1007\/s11095-020-02865-1.","journal-title":"Pharm Res"},{"key":"3941_CR81","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jconrel.2018.03.019","volume":"277","author":"M Qu","year":"2018","unstructured":"Qu M, Lin Q, He S, Wang L, Fu Y, Zhang Z, et al. A brain targeting functionalized liposomes of the dopamine derivative N-3,4-bis(pivaloyloxy)-dopamine for treatment of Parkinson\u2019s disease. J Control Release. 2018;277:173\u201382. https:\/\/doi.org\/10.1016\/j.jconrel.2018.03.019.","journal-title":"J Control Release"},{"key":"3941_CR82","doi-asserted-by":"publisher","first-page":"4123","DOI":"10.1021\/acsnano.7b08172","volume":"12","author":"L You","year":"2018","unstructured":"You L, Wang J, Liu T, Zhang Y, Han X, Wang T, et al. Targeted brain delivery of Rabies virus glycoprotein 29-modified deferoxamine-loaded nanoparticles reverses functional deficits in Parkinsonian mice. ACS Nano. 2018;12:4123\u201339. https:\/\/doi.org\/10.1021\/acsnano.7b08172.","journal-title":"ACS Nano"},{"key":"3941_CR83","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.4c01327","author":"R Prades","year":"2025","unstructured":"Prades R, Teixid\u00f3 M, Oller-Salvia B. New trends in brain shuttle peptides. Mol Pharm. 2025. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.4c01327.","journal-title":"Mol Pharm"},{"key":"3941_CR84","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3390\/pharmaceutics12010072","volume":"12","author":"GP Hoyos-Ceballos","year":"2020","unstructured":"Hoyos-Ceballos GP, Ruozi B, Ottonelli I, Da Ros F, Vandelli MA, Forni F, et al. PLGA-PEG-ANG-2 nanoparticles for blood-brain barrier crossing: proof-of-concept study. Pharmaceutics. 2020;12:72. https:\/\/doi.org\/10.3390\/pharmaceutics12010072.","journal-title":"Pharmaceutics"},{"key":"3941_CR85","doi-asserted-by":"publisher","first-page":"20326","DOI":"10.1021\/acsami.8b04613","volume":"10","author":"W Chen","year":"2018","unstructured":"Chen W, Zuo H, Zhang E, Li L, Henrich-Noack P, Cooper H, et al. Brain targeting delivery facilitated by ligand-functionalized layered double hydroxide nanoparticles. ACS Appl Mater Interfaces. 2018;10:20326\u201333. https:\/\/doi.org\/10.1021\/acsami.8b04613.","journal-title":"ACS Appl Mater Interfaces"},{"key":"3941_CR86","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1007\/s11095-013-1025-4","volume":"30","author":"J Li","year":"2013","unstructured":"Li J, Zhang C, Li J, Fan L, Jiang X, Chen J, et al. Brain delivery of NAP with PEG-PLGA nanoparticles modified with phage display peptides. Pharm Res. 2013;30:1813\u201323. https:\/\/doi.org\/10.1007\/s11095-013-1025-4.","journal-title":"Pharm Res"},{"key":"3941_CR87","doi-asserted-by":"publisher","first-page":"4943","DOI":"10.1016\/j.biomaterials.2011.03.031","volume":"32","author":"J Li","year":"2011","unstructured":"Li J, Feng L, Fan L, Zha Y, Guo L, Zhang Q, et al. Targeting the brain with PEG\u2013PLGA nanoparticles modified with phage-displayed peptides. Biomaterials. 2011;32:4943\u201350. https:\/\/doi.org\/10.1016\/j.biomaterials.2011.03.031.","journal-title":"Biomaterials"},{"key":"3941_CR88","doi-asserted-by":"publisher","first-page":"8669","DOI":"10.1016\/j.biomaterials.2011.07.069","volume":"32","author":"G Huile","year":"2011","unstructured":"Huile G, Shuaiqi P, Zhi Y, Shijie C, Chen C, Xinguo J, et al. A cascade targeting strategy for brain neuroglial cells employing nanoparticles modified with angiopep-2 peptide and EGFP-EGF1 protein. Biomaterials. 2011;32:8669\u201375. https:\/\/doi.org\/10.1016\/j.biomaterials.2011.07.069.","journal-title":"Biomaterials"},{"key":"3941_CR89","doi-asserted-by":"publisher","first-page":"306032","DOI":"10.3389\/fnins.2017.00608","volume":"11","author":"N Vinzant","year":"2017","unstructured":"Vinzant N, Scholl JL, Wu CM, Kindle T, Koodali R, Forster GL. Iron oxide nanoparticle delivery of peptides to the brain: Reversal of anxiety during drug withdrawal. Front Neurosci. 2017;11:306032. https:\/\/doi.org\/10.3389\/fnins.2017.00608.","journal-title":"Front Neurosci"},{"key":"3941_CR90","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.201909999","volume":"30","author":"L Cai","year":"2020","unstructured":"Cai L, Yang C, Jia W, Liu Y, Xie R, Lei T, et al. Endo\/Lysosome-escapable delivery depot for improving BBB transcytosis and neuron targeted therapy of Alzheimer\u2019s disease. Adv Funct Mater. 2020;30:1909999. https:\/\/doi.org\/10.1002\/adfm.201909999.","journal-title":"Adv Funct Mater"},{"key":"3941_CR91","doi-asserted-by":"publisher","first-page":"7194","DOI":"10.1016\/j.biomaterials.2012.06.063","volume":"33","author":"R Prades","year":"2012","unstructured":"Prades R, Guerrero S, Araya E, Molina C, Salas E, Zurita E, et al. Delivery of gold nanoparticles to the brain by conjugation with a peptide that recognizes the transferrin receptor. Biomaterials. 2012;33:7194\u2013205. https:\/\/doi.org\/10.1016\/j.biomaterials.2012.06.063.","journal-title":"Biomaterials"},{"key":"3941_CR92","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1021\/acsnano.8b06437","volume":"13","author":"LL Israel","year":"2019","unstructured":"Israel LL, Braubach O, Galstyan A, Chiechi A, Shatalova ES, Grodzinski Z, et al. A combination of tri-leucine and Angiopep-2 drives a polyanionic polymalic acid nanodrug platform across the blood-brain barrier. ACS Nano. 2019;13:1253\u201371. https:\/\/doi.org\/10.1021\/acsnano.8b06437.","journal-title":"ACS Nano"},{"key":"3941_CR93","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.jconrel.2020.01.039","volume":"320","author":"Q Guo","year":"2020","unstructured":"Guo Q, Xu S, Yang P, Wang P, Lu S, Sheng D, et al. A dual-ligand fusion peptide improves the brain-neuron targeting of nanocarriers in Alzheimer\u2019s disease mice. J Control Release. 2020;320:347\u201362. https:\/\/doi.org\/10.1016\/j.jconrel.2020.01.039.","journal-title":"J Control Release"},{"key":"3941_CR94","doi-asserted-by":"publisher","first-page":"1050647","DOI":"10.3389\/fnut.2022.1050647","volume":"9","author":"X Zhang","year":"2022","unstructured":"Zhang X, Li X, Zhao Y, Zheng Q, Wu Q, Yu Y. Nanocarrier system: an emerging strategy for bioactive peptide delivery. Front Nutr. 2022;9:1050647. https:\/\/doi.org\/10.3389\/fnut.2022.1050647.","journal-title":"Front Nutr"},{"key":"3941_CR95","doi-asserted-by":"publisher","first-page":"656","DOI":"10.2174\/1389203722666210920151810","volume":"22","author":"A Yadav","year":"2021","unstructured":"Yadav A, Pandey D, Ashraf GMD, Rachana. Peptide based therapy for neurological disorders. Curr Protein Pept Sci. 2021;22:656\u201365. https:\/\/doi.org\/10.2174\/1389203722666210920151810.","journal-title":"Curr Protein Pept Sci"},{"key":"3941_CR96","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.ijpharm.2017.04.033","volume":"525","author":"X Zheng","year":"2017","unstructured":"Zheng X, Zhang C, Guo Q, Wan X, Shao X, Liu Q, et al. Dual-functional nanoparticles for precise drug delivery to Alzheimer\u2019s disease lesions: targeting mechanisms, pharmacodynamics and safety. Int J Pharm. 2017;525:237\u201348. https:\/\/doi.org\/10.1016\/j.ijpharm.2017.04.033.","journal-title":"Int J Pharm"},{"key":"3941_CR97","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.jconrel.2014.07.050","volume":"192","author":"C Zhang","year":"2014","unstructured":"Zhang C, Zheng X, Wan X, Shao X, Liu Q, Zhang Z, et al. The potential use of H102 peptide-loaded dual-functional nanoparticles in the treatment of Alzheimer\u2019s disease. J Control Release. 2014;192:317\u201324. https:\/\/doi.org\/10.1016\/j.jconrel.2014.07.050.","journal-title":"J Control Release"},{"key":"3941_CR98","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.jconrel.2023.01.074","volume":"355","author":"Q Guo","year":"2023","unstructured":"Guo Q, Li Y, Xu S, Wang P, Qian K, Yang P, et al. Brain-neuron targeted nanoparticles for peptide synergy therapy at dual-target of Alzheimer\u2019s disease. J Control Release. 2023;355:604\u201321. https:\/\/doi.org\/10.1016\/j.jconrel.2023.01.074.","journal-title":"J Control Release"},{"key":"3941_CR99","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202504517","author":"S Han","year":"2025","unstructured":"Han S, Utami RN, Qin Y, Liam-Or R, Sreedharan J, Davies JS, et al. Nose-to-brain delivery of acyl-ghrelin peptide gold nanoconjugates for treatment of neurodegenerative diseases. Small. 2025. https:\/\/doi.org\/10.1002\/smll.202504517.","journal-title":"Small"},{"key":"3941_CR100","doi-asserted-by":"publisher","first-page":"6866","DOI":"10.1021\/acsnano.0c00866","volume":"14","author":"P Valente","year":"2020","unstructured":"Valente P, Kiryushko D, Sacchetti S, Machado P, Cobley CM, Mangini V, et al. Conopeptide-functionalized nanoparticles selectively antagonize extrasynaptic N-methyl- d -aspartate receptors and protect hippocampal neurons from excitotoxicity in vitro. ACS Nano. 2020;14:6866\u201377.","journal-title":"ACS Nano"},{"key":"3941_CR101","doi-asserted-by":"publisher","first-page":"4071","DOI":"10.1021\/acsomega.7b00458","volume":"2","author":"P Di Pietro","year":"2017","unstructured":"Di Pietro P, Caporarello N, Anfuso CD, Lupo G, Magr\u00ec A, La Mendola D, et al. Immobilization of neurotrophin peptides on gold nanoparticles by direct and lipidmediated interaction: a new multipotential therapeutic nanoplatform for CNS disorders. ACS Omega. 2017;2:4071\u20139. https:\/\/doi.org\/10.1021\/acsomega.7b00458.","journal-title":"ACS Omega"},{"key":"3941_CR102","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1007\/s12031-014-0438-9","volume":"55","author":"ZR Xu","year":"2015","unstructured":"Xu ZR, Wang WF, Liang XF, Liu ZH, Liu Y, Lin L, et al. Protective effects of poly (butyl) cyanoacrylate nanoparticles containing vasoactive intestinal peptide against 6-hydroxydopamine-induced neurotoxicity in vitro. J Mol Neurosci. 2015;55:854\u201364. https:\/\/doi.org\/10.1007\/s12031-014-0438-9.","journal-title":"J Mol Neurosci"},{"key":"3941_CR103","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.nano.2016.10.006","volume":"13","author":"M Gregori","year":"2017","unstructured":"Gregori M, Taylor M, Salvati E, Re F, Mancini S, Balducci C, et al. Retro-inverso peptide inhibitor nanoparticles as potent inhibitors of aggregation of the Alzheimer\u2019s A\u03b2 peptide. Nanomedicine. 2017;13:723\u201332. https:\/\/doi.org\/10.1016\/j.nano.2016.10.006.","journal-title":"Nanomedicine"},{"key":"3941_CR104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12951-016-0212-y","volume":"14","author":"M Plissonneau","year":"2016","unstructured":"Plissonneau M, Pansieri J, Heinrich-Balard L, Morfin JF, Stransky-Heilkron N, Rivory P, et al. Gd-nanoparticles functionalization with specific peptides for \u00df-amyloid plaques targeting. J Nanobiotechnology. 2016;14:1\u201315. https:\/\/doi.org\/10.1186\/s12951-016-0212-y.","journal-title":"J Nanobiotechnology"},{"key":"3941_CR105","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.jconrel.2019.11.009","volume":"317","author":"G Kim","year":"2020","unstructured":"Kim G, Kim M, Lee Y, Byun JW, Hwang DW, Lee M. Systemic delivery of microRNA-21 antisense oligonucleotides to the brain using T7-peptide decorated exosomes. J Control Release. 2020;317:273\u201381. https:\/\/doi.org\/10.1016\/j.jconrel.2019.11.009.","journal-title":"J Control Release"},{"key":"3941_CR106","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/psc.2640","volume":"20","author":"AS Joshi","year":"2014","unstructured":"Joshi AS, Thakur AK. Biodegradable delivery system containing a peptide inhibitor of polyglutamine aggregation: a step toward therapeutic development in Huntington\u2019s disease. J Peptide Sci. 2014;20:630\u20139. https:\/\/doi.org\/10.1002\/psc.2640.","journal-title":"J Peptide Sci"},{"key":"3941_CR107","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.1002\/alz.13015","volume":"19","author":"EA Meyers","year":"2023","unstructured":"Meyers EA, Sexton C, Snyder HM, Carrillo MC. Impact of Alzheimer\u2019s association support and engagement in the AD\/ADRD research community through the COVID-19 pandemic and beyond. Alzheimers Dement. 2023;19:3222\u20135. https:\/\/doi.org\/10.1002\/alz.13015.","journal-title":"Alzheimers Dement"},{"key":"3941_CR108","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12951-018-0340-7","volume":"16","author":"Y Shen","year":"2018","unstructured":"Shen Y, Cao B, Snyder NR, Woeppel KM, Eles JR, Cui XT. ROS responsive resveratrol delivery from LDLR peptide conjugated PLA-coated mesoporous silica nanoparticles across the blood-brain barrier. J Nanobiotechnol. 2018;16:1\u201317. https:\/\/doi.org\/10.1186\/s12951-018-0340-7.","journal-title":"J Nanobiotechnol"},{"key":"3941_CR109","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202203182","author":"X Yang","year":"2022","unstructured":"Yang X, Yang W, Xia X, Lei T, Yang Z, Jia W, et al. Intranasal delivery of BACE1 siRNA and rapamycin by dual targets modified nanoparticles for Alzheimer\u2019s disease therapy. Small. 2022. https:\/\/doi.org\/10.1002\/smll.202203182.","journal-title":"Small"},{"key":"3941_CR110","doi-asserted-by":"publisher","first-page":"118449","DOI":"10.1016\/j.jtice.2021.11.009","volume":"567","author":"L Gan","year":"2019","unstructured":"Gan L, Li Z, Lv Q, Huang W. Rabies virus glycoprotein (RVG29)-linked microRNA-124-loaded polymeric nanoparticles inhibit neuroinflammation in a Parkinson\u2019s disease model. Int J Pharm. 2019;567:118449. https:\/\/doi.org\/10.1016\/j.jtice.2021.11.009.","journal-title":"Int J Pharm"},{"key":"3941_CR111","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1021\/acsbiomaterials.3c01622","volume":"10","author":"P Jiang","year":"2024","unstructured":"Jiang P, Xiao Y, Hu X, Wang C, Gao H, Huang H, et al. Rvg29 peptide-modified exosomes loaded with Mir-133b mediate the RhoA-ROCK pathway to improve motor and neurological symptoms in Parkinson\u2019s disease. ACS Biomater Sci Eng. 2024;10:3069\u201385. https:\/\/doi.org\/10.1021\/acsbiomaterials.3c01622.","journal-title":"ACS Biomater Sci Eng"},{"key":"3941_CR112","doi-asserted-by":"publisher","first-page":"8199","DOI":"10.1021\/acsami.3c13849","volume":"16","author":"J Zhang","year":"2024","unstructured":"Zhang J, Cui B, He T, Hei R, Yang L, Liu C, et al. Enhancing neuroprotection in mouse model of Parkinson\u2019s disease through protein nanosystem conjugation with ApoE peptide for miR-124 delivery. ACS Appl Mater Interfaces. 2024;16:8199\u2013212. https:\/\/doi.org\/10.1021\/acsami.3c13849.","journal-title":"ACS Appl Mater Interfaces"},{"key":"3941_CR113","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s12035-017-0728-7","volume":"55","author":"S Hernando","year":"2018","unstructured":"Hernando S, Herran E, Figueiro-Silva J, Pedraz JL, Igartua M, Carro E, et al. Intranasal administration of TAT-conjugated lipid nanocarriers loading GDNF for Parkinson\u2019s disease. Mol Neurobiol. 2018;55:145\u201355. https:\/\/doi.org\/10.1007\/s12035-017-0728-7.","journal-title":"Mol Neurobiol"},{"key":"3941_CR114","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.621996","volume":"15","author":"EN Minakawa","year":"2021","unstructured":"Minakawa EN, Nagai Y. Protein aggregation inhibitors as disease-modifying therapies for polyglutamine diseases. Front Neurosci. 2021;15:621996. https:\/\/doi.org\/10.3389\/fnins.2021.621996.","journal-title":"Front Neurosci"},{"key":"3941_CR115","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1021\/acschemneuro.8b00545","volume":"10","author":"AS Joshi","year":"2019","unstructured":"Joshi AS, Singh V, Gahane A, Thakur AK. Biodegradable nanoparticles containing mechanism based peptide inhibitors reduce polyglutamine aggregation in cell models and alleviate motor symptoms in a Drosophila model of Huntington\u2019s disease. ACS Chem Neurosci. 2019;10:1603\u201314. https:\/\/doi.org\/10.1021\/acschemneuro.8b00545.","journal-title":"ACS Chem Neurosci"},{"key":"3941_CR116","doi-asserted-by":"publisher","first-page":"4838","DOI":"10.1021\/acsbiomaterials.2c00865","volume":"8","author":"D D\u00edaz-Garc\u00eda","year":"2022","unstructured":"D\u00edaz-Garc\u00eda D, Ferrer-Donato \u00c1, M\u00e9ndez-Arriaga JM, Cabrera-Pinto M, D\u00edaz-S\u00e1nchez M, Prashar S, et al. Design of mesoporous silica nanoparticles for the treatment of amyotrophic lateral sclerosis (ALS) with a therapeutic cocktail based on leptin and pioglitazone. ACS Biomater Sci Eng. 2022;8:4838\u201349. https:\/\/doi.org\/10.1021\/acsbiomaterials.2c00865.","journal-title":"ACS Biomater Sci Eng"},{"key":"3941_CR117","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124218","volume":"658","author":"SR Saleh","year":"2024","unstructured":"Saleh SR, Abd-Elmegied A, Aly Madhy S, Khattab SN, Sheta E, Elnozahy FY, et al. Brain-targeted Tet-1 peptide-PLGA nanoparticles for berberine delivery against STZ-induced Alzheimer\u2019s disease in a rat model: alleviation of hippocampal synaptic dysfunction, Tau pathology, and amyloidogenesis. Int J Pharm. 2024;658:124218. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124218.","journal-title":"Int J Pharm"},{"key":"3941_CR118","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.125021","volume":"669","author":"SR Saleh","year":"2025","unstructured":"Saleh SR, Khamiss SE, Aly Madhy S, Khattab SN, Sheta E, Elnozahy FY, et al. Biochemical investigation and in silico analysis of the therapeutic efficacy of Ipriflavone through Tet-1 Surface-Modified-PLGA nanoparticles in Streptozotocin-induced Alzheimer\u2019s like disease: reduced oxidative damage and etiological descriptors. Int J Pharm. 2025;669:125021. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.125021.","journal-title":"Int J Pharm"},{"key":"3941_CR119","doi-asserted-by":"publisher","first-page":"8475","DOI":"10.1021\/am501341u","volume":"6","author":"J Zhang","year":"2014","unstructured":"Zhang J, Zhou X, Yu Q, Yang L, Sun D, Zhou Y, et al. Epigallocatechin-3-gallate (EGCG)-stabilized selenium nanoparticles coated with Tet-1 peptide to reduce amyloid-\u03b2 aggregation and cytotoxicity. ACS Appl Mater Interfaces. 2014;6:8475\u201387. https:\/\/doi.org\/10.1021\/am501341u.","journal-title":"ACS Appl Mater Interfaces"},{"key":"3941_CR120","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2022.123125","volume":"230","author":"Y Feng","year":"2023","unstructured":"Feng Y, Li X, Ji D, Tian J, Peng Q, Shen Y, et al. Functionalised penetrating peptide-chondroitin sulphate-gold nanoparticles: Synthesis, characterization, and applications as an anti-Alzheimer\u2019s disease drug. Int J Biol Macromol. 2023;230:123125. https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.123125.","journal-title":"Int J Biol Macromol"},{"key":"3941_CR121","doi-asserted-by":"publisher","first-page":"12748","DOI":"10.1039\/D3NR01558K","volume":"15","author":"A Kour","year":"2023","unstructured":"Kour A, Tiwari V, Aggarwal N, Sekhar Panda H, Kumar A, Tiwari S, et al. Anti-amyloidogenic amphipathic arginine-dehydrophenylalanine spheres capped selenium nanoparticles as potent therapeutic moieties for Alzheimer\u2019s disease. Nanoscale. 2023;15:12748\u201370. https:\/\/doi.org\/10.1039\/D3NR01558K.","journal-title":"Nanoscale"},{"key":"3941_CR122","doi-asserted-by":"publisher","first-page":"61774","DOI":"10.1021\/acsami.4c16337","volume":"16","author":"Y Tang","year":"2024","unstructured":"Tang Y, Song X, Xiao M, Wang C, Zhang X, Li P, et al. Inhibition of A\u03b2 aggregation and tau phosphorylation with functionalized biomimetic nanoparticles for synergic Alzheimer\u2019s disease therapy. ACS Appl Mater Interface. 2024;16:61774\u201386. https:\/\/doi.org\/10.1021\/acsami.4c16337.","journal-title":"ACS Appl Mater Interface"},{"key":"3941_CR123","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241914954","volume":"24","author":"M Choi","year":"2023","unstructured":"Choi M, Ryu J, Vu HD, Kim D, Youn YJ, Park MH, et al. Transferrin-conjugated melittin-loaded L-arginine-coated iron oxide nanoparticles for mitigating beta-amyloid pathology of the 5XFAD mouse brain. Int J Mol Sci. 2023;24:14954. https:\/\/doi.org\/10.3390\/ijms241914954.","journal-title":"Int J Mol Sci"},{"key":"3941_CR124","doi-asserted-by":"publisher","first-page":"46406","DOI":"10.1021\/acsami.1c14818","volume":"13","author":"C Li","year":"2021","unstructured":"Li C, Wang N, Zheng G, Yang L. Oral administration of Resveratrol-Selenium-Peptide nanocomposites alleviates Alzheimer\u2019s disease-like pathogenesis by inhibiting A\u03b2 aggregation and regulating gut microbiota. ACS Appl Mater Interfaces. 2021;13:46406\u201320. https:\/\/doi.org\/10.1021\/acsami.1c14818.","journal-title":"ACS Appl Mater Interfaces"},{"key":"3941_CR125","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.1126\/sciadv.adl2991","volume":"10","author":"K Hou","year":"2024","unstructured":"Hou K, Pan H, Shahpasand-Kroner H, Hu C, Abskharon R, Seidler P, et al. D-peptide- magnetic nanoparticles fragment tau fibrils and rescue behavioral deficits in a mouse model of Alzheimer\u2019s disease. Sci Adv. 2024;10:2991. https:\/\/doi.org\/10.1126\/sciadv.adl2991.","journal-title":"Sci Adv"},{"key":"3941_CR126","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1021\/bc400055h","volume":"24","author":"Z Liu","year":"2013","unstructured":"Liu Z, Gao X, Kang T, Jiang M, Miao D, Gu G, et al. B6 peptide-modified PEG-PLA nanoparticles for enhanced brain delivery of neuroprotective peptide. Bioconjug Chem. 2013;24:997\u20131007.","journal-title":"Bioconjug Chem"},{"key":"3941_CR127","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1080\/10717544.2018.1461955","volume":"25","author":"S Fan","year":"2018","unstructured":"Fan S, Zheng Y, Liu X, Fang W, Chena X, Liao W, et al. Curcumin-loaded plga-peg nanoparticles conjugated with b6 peptide for potential use in alzheimer\u2019s disease. Drug Deliv. 2018;25:1044\u201355. https:\/\/doi.org\/10.1080\/10717544.2018.1461955.","journal-title":"Drug Deliv"},{"key":"3941_CR128","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.10395","volume":"7","author":"R Zhou","year":"2022","unstructured":"Zhou R, Zhu L, Zeng Z, Luo R, Zhang J, Guo R, et al. Targeted brain delivery of RVG29-modified rifampicin-loaded nanoparticles for Alzheimer\u2019s disease treatment and diagnosis. Bioeng Transl Med. 2022;7:e10395. https:\/\/doi.org\/10.1002\/btm2.10395.","journal-title":"Bioeng Transl Med"},{"key":"3941_CR129","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2023.120714","volume":"310","author":"L Yang","year":"2023","unstructured":"Yang L, Wang Y, Li Z, Wu X, Mei J, Zheng G. Brain targeted peptide-functionalized chitosan nanoparticles for resveratrol delivery: impact on insulin resistance and gut microbiota in obesity-related Alzheimer\u2019s disease. Carbohydr Polym. 2023;310:120714. https:\/\/doi.org\/10.1016\/j.carbpol.2023.120714.","journal-title":"Carbohydr Polym"},{"key":"3941_CR130","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jconrel.2011.02.022","volume":"151","author":"Z Wen","year":"2011","unstructured":"Wen Z, Yan Z, Hu K, Pang Z, Cheng X, Guo L, et al. Odorranalectin-conjugated nanoparticles: Preparation, brain delivery and pharmacodynamic study on Parkinson\u2019s disease following intranasal administration. J Control Release. 2011;151:131\u20138. https:\/\/doi.org\/10.1016\/j.jconrel.2011.02.022.","journal-title":"J Control Release"},{"key":"3941_CR131","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1007\/s11095-013-1005-8","volume":"30","author":"R Huang","year":"2013","unstructured":"Huang R, Ma H, Guo Y, Liu S, Kuang Y, Shao K, et al. Angiopep-conjugated nanoparticles for targeted long-term gene therapy of parkinson\u2019s disease. Pharm Res. 2013;30:2549\u201359. https:\/\/doi.org\/10.1007\/s11095-013-1005-8.","journal-title":"Pharm Res"},{"key":"3941_CR132","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1016\/j.xcrp.2025.102624","volume":"8","author":"Y Liu","year":"2022","unstructured":"Liu Y, Luo J, Liu Y, Liu W, Yu G, Huang Y, et al. Brain-targeted biomimetic nanodecoys with neuroprotective effects for precise therapy of Parkinson\u2019s disease. ACS Cent Sci. 2022;8:1336\u201349. https:\/\/doi.org\/10.1016\/j.xcrp.2025.102624.","journal-title":"ACS Cent Sci"},{"key":"3941_CR133","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtice.2021.11.009","volume":"132","author":"YC Kuo","year":"2022","unstructured":"Kuo YC, Feng KC, Rajesh R. Rabies virus glycoprotein- and transferrin-functionalized liposomes to elevate epigallocatechin gallate and FK506 activity and mediate MAPK against neuronal apoptosis in Parkinson\u2019s disease. J Taiwan Inst Chem Eng. 2022;132:104142. https:\/\/doi.org\/10.1016\/j.jtice.2021.11.009.","journal-title":"J Taiwan Inst Chem Eng"},{"key":"3941_CR134","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.15252\/emmm.201505413","volume":"7","author":"M Valenza","year":"2015","unstructured":"Valenza M, Chen JY, Di Paolo E, Ruozi B, Belletti D, Ferrari Bardile C, et al. Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in H untington\u2019s disease mice. EMBO Mol Med. 2015;7:1547\u201364. https:\/\/doi.org\/10.15252\/emmm.201505413.","journal-title":"EMBO Mol Med"},{"key":"3941_CR135","doi-asserted-by":"publisher","first-page":"60894","DOI":"10.1021\/acsami.1c18754","volume":"13","author":"D Wahyuningtyas","year":"2021","unstructured":"Wahyuningtyas D, Chen WH, He RY, Huang YA, Tsao CK, He YJ, et al. Polyglutamine-specific gold nanoparticle complex alleviates mutant Huntingtin-induced toxicity. ACS Appl Mater Interfaces. 2021;13:60894\u2013906. https:\/\/doi.org\/10.1021\/acsami.1c18754.","journal-title":"ACS Appl Mater Interfaces"},{"key":"3941_CR136","doi-asserted-by":"publisher","DOI":"10.1016\/j.mito.2025.102038","author":"S Kshirsagar","year":"2025","unstructured":"Kshirsagar S, Reddy AP, Reddy PH. Beneficial effects of mitophagy enhancers on amyloid beta-induced mitochondrial and synaptic toxicities in Alzheimer\u2019s disease. Mitochondrion. 2025. https:\/\/doi.org\/10.1016\/j.mito.2025.102038.","journal-title":"Mitochondrion"},{"key":"3941_CR137","doi-asserted-by":"publisher","DOI":"10.1016\/j.mito.2025.102036","volume":"83","author":"S Kshirsagar","year":"2025","unstructured":"Kshirsagar S, Alvir RV, Pradeepkiran JA, Reddy AP, Reddy PH. Therapeutic potential of DDQ in enhancing mitochondrial health and cognitive function in late-onset Alzheimer\u2019s disease. Mitochondrion. 2025;83:102036. https:\/\/doi.org\/10.1016\/j.mito.2025.102036.","journal-title":"Mitochondrion"},{"key":"3941_CR138","unstructured":"Boston: Neuroprotective peptide inches forward in clinic | ALZFORUM https:\/\/www.alzforum.org\/news\/conference-coverage\/boston-neuroprotective-peptide-inches-forward-clinic"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-025-03941-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-025-03941-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-025-03941-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T16:50:38Z","timestamp":1768927838000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11095-025-03941-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,6]]},"references-count":138,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["3941"],"URL":"https:\/\/doi.org\/10.1007\/s11095-025-03941-0","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,6]]},"assertion":[{"value":"5 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human and animal subjects performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research Involving in Human and Animal Rights"}},{"value":"All authors (Anil Kumar, Prashantha K and Ranjitha VR) declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}